Clinical Trial Results TV
March 9, 2007: Reperfusion Reflections
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Reflections on Reperfusion
* Evolution of Timing of Pharmacologic Reperfusion
* Primary PCI: The Need for Excellence
* PPCI in STEMI: Time & Risk
* Clinical Outcomes
* PPCI vs Fibrinolysis for STEMI
* Primary 30-day Endpoint DANAMI-2
* DANAMI-2: Reflections on NEJM Publication
* DANAMI-2: 3-yr Mortality & Risk A New Perspective
* Survival Advantage: PPCI vs Lytics

The moderator, Kristin Newby, MD, has indicated that she receives research/grant support
from Bristol-Myers Squibb, Sanofi, Millennium Pharmaceuticals, Inc., Schering-Plough
Research Institute, Novartis and Roche Diagnostics Corporation. Dr. Newby is also a member
of an advisory board for Eli Lilly and a consultant for Proctor and Gamble; she has spoken
at scientific symposia for Aventis, Bristol-Myers Squibb, Sanofi and Millennium
Pharmaceuticals, Inc.

The guest faculty, Paul W. Armstrong, MD, has indicated that he receives research/grant
support from Boehringer-Ingelheim, Hoffman-LaRoche and sanofi-aventis. He also serves as a
consultant for sanofi-aventis and Hoffman-LaRoche.



Reperfusion Reflections

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
12-13-2018 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted